rict Court for the District of Florida on Monday, March 3 refused to fully throw out a class-action suit implicating the company. Gilead, along with Bristol-Myers Squibb, Japan Tobacco, and Johnson & Johnson, have been accused of restricting competition in the HIV drug market, which is dominated by Gilead. [Continue